BNP/CALL/STRYKER CORP./380/0.1/20.09.24 Share Price

Warrant

DE000PC5FYD0

Market Closed - Börse Stuttgart 07:36:47 14/06/2024 BST
0.35 EUR -14.63% Intraday chart for BNP/CALL/STRYKER CORP./380/0.1/20.09.24
Current month-16.67%
1 month+66.67%
Date Price Change
14/06/24 0.35 -14.63%
13/06/24 0.41 -10.87%
12/06/24 0.46 -2.13%
11/06/24 0.47 0.00%
10/06/24 0.47 -11.32%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 07:36 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5FYD
ISINDE000PC5FYD0
Date issued 21/02/2024
Strike 380 $
Maturity 20/09/2024 (97 Days)
Parity 10 : 1
Emission price 1.35
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.75
Lowest since issue 0.19
Spread 0.05
Spread %10.87%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
345 USD
Average target price
372.5 USD
Spread / Average Target
+7.98%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW